Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01460225 · ClinicalTrials.gov registry record · Phase 4
Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation
A Phase 4 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT01460225: Completed Phase 4 study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT01460225 is a Phase 4 study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 19 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01460225, a Phase 4 study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
This prospective study is designed to evaluate how lubiprostone may affect gastric motor and sensory function.
Primary Outcome
gastric emptying was measured before and after 7 days of treatment.at set times (2 and 4 hours post eating a radio-labeled meal)
Interventions
- DRUG lubiprostone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2007-09 |
| Est. Completion | 2011-01 |
| Phase | Phase 4 |
What the finished NCT01460225 record still lists
NCT01460225 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which lubiprostone is the first listed.
NCT01460225 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01460225 about?
NCT01460225 is a clinical study titled "Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation". This prospective study is designed to evaluate how lubiprostone may affect gastric motor and sensory function.
What is the current status of trial NCT01460225?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2007-09. Estimated completion is 2011-01.
What interventions are being tested in trial NCT01460225?
The interventions under investigation include: lubiprostone (DRUG).
Who is sponsoring clinical trial NCT01460225?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01460225's enrollment target sits among peer trials
19 1834th of 2000 higher than 159 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia